Fludarabine/full dose i.v. busulfan conditioning regimen in allogeneic PBSC transplantation for high risk patients

被引：0
|
作者：
Chunduri, S. [1 ]
Dobogai, L. C. [1 ]
Peace, D. [1 ]
Saunthararajah, Y. [1 ]
Quigley, J. [1 ]
Chen, Y. -H. [1 ]
Boccuni, P. [1 ]
Hoffman, R. [1 ]
Mahmud, N. [1 ]
Beri, R. [1 ]
Hurter, E. [1 ]
Rondelli, D. [1 ]
机构：
[1] Univ Illinois, Hematol Oncol Sect, Chicago, IL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2006.12.235
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [31] Fludarabine and busulfan (FluBu regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukaemic patients (a single centre study)
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Evazi, MR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S218 - S219
  • [32] Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoetic stem cell transplantation (alloHCT)
    O'Donnell, P. H.
    Artz, A. S.
    Undevia, S. D.
    Hart, J.
    van Besien, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Fludarabine Melphalan, Reduced-dose Busulfan Versus Fludarabine, Melphalan, Full-dose Busulfan in Patients Receiving Cord Blood Transplantation
    Arai, Nana
    Narita, Hinako
    Kuroiwa, Kai
    Nagao, Kazuki
    Hayashi, Hidenori
    Kawamata, Natsuki
    Okamura, Reiko
    Sasaki, Yohei
    Shimada, Shotaro
    Watanuki, Megumi
    Kawaguchi, Yukiko
    Yanagisawa, Kouji
    Hattori, Norimichi
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (08) : 1828 - 1835
  • [34] Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
    Jiang, Jieling
    Li, Xiaofan
    Wu, Dong
    Lu, Quanyi
    Miao, Kourong
    Wang, Houcai
    Li, Xiaoping
    Chen, Yingnian
    Zhou, Shiyuan
    Zhou, Yali
    Liao, Guiping
    Jiang, Chuanhe
    Yuan, Xiaohong
    Zhao, Youshan
    Chang, Chunkang
    Chen, Jie
    Zhu, Han
    Ma, Ruye
    Li, Nainong
    Yin, Xiaolin
    Wu, Xiaojin
    Wang, Sanbin
    Wang, Chun
    Hu, Jiong
    EJHAEM, 2024, 5 (04): : 757 - 767
  • [35] Peri-Engraftment Mucositis Amongst Patients Receiving Intravenous Busulfan/Fludarabine as Conditioning Regimen for Allogeneic Hemopoietic Stem Cell Transplantation
    Deol, Abhinav
    Manickam, Palaniappan
    Uberti, Joseph
    Ratanatharathorn, Voravit
    Lum, Lawrence G.
    Ayash, Lois
    Abidi, Muneer H.
    Abrams, Judith
    Al-Kadhimi, Zaid
    BLOOD, 2009, 114 (22) : 1299 - 1299
  • [36] Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
    Andersson, Borje S.
    Valdez, Benigno C.
    de Lima, Marcos
    Wang, Xuemei
    Thall, Peter F.
    Worth, Laura L.
    Popat, Uday
    Madden, Timothy
    Hosing, Chitra
    Alousi, Amin
    Rondon, Gabriela
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Jones, Roy B.
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 893 - 900
  • [37] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    M Cavo
    G Bandini
    M Benni
    A Gozzetti
    S Ronconi
    G Rosti
    E Zamagni
    RM Lemoli
    A Bonini
    A Belardinelli
    MR Motta
    S Rizzi
    S Tura
    Bone Marrow Transplantation, 1998, 22 : 27 - 32
  • [38] A PHASE I STUDY OF CLOFARABINE PLUS HIGH DOSE MELPHALAN AS A CONDITIONING REGIMEN FOR ALLOGENEIC TRANSPLANTATION
    Kirschbaum, M.
    Stein, A. S.
    Nakamura, R.
    Nademanee, A.
    Popplewell, L.
    Delioukina, M.
    Chen, R.
    Snyder, D.
    Conrad, J.
    Frankel, P.
    Forman, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 64 - 65
  • [39] High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
    Cavo, M
    Bandini, G
    Benni, M
    Gozzetti, A
    Ronconi, S
    Rosti, G
    Zamagni, E
    Lemoli, RM
    Bonini, A
    Belardinelli, A
    Motta, MR
    Rizzi, S
    Tura, S
    BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 27 - 32
  • [40] The Efficacy and Safety of Busulfan Dose Intensity with Fludarabine Conditioning Regimen for Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation. A Single Center Experience
    Massoud, Radwan
    Heller, Raban
    Moukalled, Nour
    Matar, Charbel
    Haffar, Basel
    Bazarbachi, Ali
    El-Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S310 - S311
12345